editor.mrrjournal@gmail.com +91-9650568176 E-ISSN: 2584-184X
Submit Paper

MRR

  • Home
  • About Us
    • INDEXING
    • JOURNAL POLIICY
    • PLAGIARISM POLICY
    • PEER REVIEW POLICY
    • OPEN ACCESS POLICY
    • PUBLICATION ETHICS
    • PRIVACY STATEMENT
  • Editorial Board
  • Publication Info
    • Article Submission
    • Submission Guidelines
    • Publication Ethics
    • Journal Policies
    • Aim and Scope
  • Articles & Issues
    • Current Issue
    • Archives
  • Authors Instruction
  • Contact

MRR Journal

Indian Journal of Modern Research and Reviews, 2024; 2(10):06-12

Severe Preeclampsia Before 34 Weeks of Amenorrhea: Management and Maternal-Fetal Prognosis

Authors: Marwen Nadia; Gueguez Ameni; Bellakhal Cenda; Tarhouni; Khouloud; Dinari; Amrou; Aidi Hadhemi;

1. Obstetrics and Gynecology Service Ibn Jazzer Kairouan Hospital, Tunisia

2. Obstetrics and Gynecology Service Ibn Jazzer Kairouan Hospital, Tunisia

3. Obstetrics and Gynecology Service Ibn Jazzer Kairouan Hospital, Tunisia

4. Obstetrics and Gynecology Service Ibn Jazzer Kairouan Hospital, Tunisia

5. Obstetrics and Gynecology Service Ibn Jazzer Kairouan Hospital, Tunisia

6. Obstetrics and Gynecology Service Ibn Jazzer Kairouan Hospital, Tunisia

7. Obstetrics and Gynecology Service Ibn Jazzer Kairouan Hospital, Tunisia

8. Obstetrics and Gynecology Service Ibn Jazzer Kairouan Hospital, Tunisia

Paper Type: Research Paper
Article Information
Received: 2024-07-26   |   Accepted: 2024-08-16   |   Published: 2024-10-17
Abstract

Introduction: Pre-eclampsia is said to be severe when associated with severe hypertension, i.e. PAS≥ 160 mmHg or PAD ≥ 110 mmHg, or when accompanied by clinical and/or biological signs of visceral distress.  It is said to be early if it occurs before 34SA. This study aimed to describe the epidemiological profile of women hospitalized for severe pre-eclampsia before 34 weeks gestation, determine the management modalities et evaluate the maternal-fetal prognosis.

Materials and Methods: This is a retrospective descriptive study carried out in the gynecology and obstetrics department at Ibn Jazzar University Hospital in Kairouan-Tunisia. Our study is conducted over 2 years from January 1, 2021, to December 31, 2023.

Results: We selected a total of 160 patients, representing a prevalence of 1.14%. The mean term on admission was 29SA+3 days. Blood pressure was greater than 180/110mmHg in 17.5% of patients. 22 patients had hepatic cytolysis. Intrauterine growth retardation was observed in 29.4% of cases, and oligohydramnios in 14.4%. 9 pregnancies were complicated by fetal death in utero. Umbilical Doppler was pathological in 20% of cases. 81% of patients were on antihypertensive treatment; 27% were on dual therapy. 91.9% of patients had received corticosteroid therapy and 52.5% had received magnesium sulfate. 24-hour proteinuria (PU 24h) averaged 4.8g/24h. The mean gestational age at delivery was 30SA+4 days, and delivery was by cesarean section in 91.9% of cases, with 128 live newborns and 33 cases of therapeutic termination of pregnancy. 74.2% of births were transferred to the neonatal intensive care unit. Post-partum, 10.6% of patients developed HELLP syndrome, and 20 patients required transfer to the intensive care unit. The average hospital stay was 7 days.

Conclusion: Corticosteroid therapy and magnesium sulfate are essential in this pathology to improve the maternal-fetal prognosis before fetal extraction, which is the only etiological treatment.

Keywords

Preeclampsia, Proteinuria, Maternal-fetal prognosis.

How to Cite

. Severe Preeclampsia Before 34 Weeks of Amenorrhea: Management and Maternal-Fetal Prognosis. Indian Journal of Modern Research and Reviews. 2024; 2(10):06-12

Download PDF

Useful Links

  • Home
  • About us
  • Editorial Board
  • Current Issue
  • All Issues
  • Submit Paper

Indexing

MRR

Contact Us

Phone: +91-9650568176
Email: editor.mrrjournal@gmail.com | editor.mrrjournal@gmail.com

© Copyright MRR 2023. All Rights Reserved